Search Results - "Muczynski, Vincent"

Refine Results
  1. 1

    Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc by Sefiane, Thibaud, Maynadié, Hortense, Ettingshausen, Carmen Escurola, Muczynski, Vincent, Heiligenstein, Xavier, Dumont, Julien, Christophe, Olivier D, Denis, Cécile V, Casari, Caterina, Lenting, Peter J

    Published in Haematologica (Roma) (01-06-2024)
    “…Recombinant factor VIII (rFVIII), rFVIIIFc and emicizumab are established treatment options in the management of hemophilia A. Each has its unique mode of…”
    Get full text
    Journal Article
  2. 2

    Macrophage scavenger receptor SR-AI contributes to the clearance of von Willebrand factor by Wohner, Nikolett, Muczynski, Vincent, Mohamadi, Amel, Legendre, Paulette, Proulle, Valérie, Aymé, Gabriel, Christophe, Olivier D, Lenting, Peter J, Denis, Cécile V, Casari, Caterina

    Published in Haematologica (Roma) (01-04-2018)
    “…Previously, we found that LDL-receptor related protein-1 on macrophages mediated shear stress-dependent clearance of von Willebrand factor. In control…”
    Get full text
    Journal Article
  3. 3

    Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC by Harrasser, Micaela, Gohil, Satyen Harish, Lau, Hiu, Della Peruta, Marco, Muczynski, Vincent, Patel, Dominic, Miranda, Elena, Grigoriadis, Kristiana, Grigoriadis, Anita, Granger, David, Evans, Rachel, Nathwani, Amit Chunilal

    Published in Breast cancer research : BCR (03-06-2022)
    “…Chimeric antigen receptor (CAR)-T cells can induce powerful immune responses in patients with hematological malignancies but have had limited success against…”
    Get full text
    Journal Article
  4. 4

    Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity by Pepin, Marion, Mezouar, Soraya, Pegon, Julie, Muczynski, Vincent, Adam, Frédéric, Bianchini, Elsa P., Bazaa, Amine, Proulle, Valerie, Rupin, Alain, Paysant, Jerome, Panicot-Dubois, Laurence, Christophe, Olivier D., Dubois, Christophe, Lenting, Peter J., Denis, Cécile V.

    Published in Scientific reports (28-11-2016)
    “…Interactions between endothelial selectins and the leukocyte counter-receptor PSGL1 mediates leukocyte recruitment to inflammation sites. PSGL1 is highly…”
    Get full text
    Journal Article
  5. 5

    Cellular and molecular effect of MEHP Involving LXRα in human fetal testis and ovary by Muczynski, Vincent, Lecureuil, Charlotte, Messiaen, Sébastien, Guerquin, Marie-Justine, N'tumba-Byn, Thierry, Moison, Delphine, Hodroj, Wassim, Benjelloun, Hinde, Baijer, Jan, Livera, Gabriel, Frydman, René, Benachi, Alexandra, Habert, René, Rouiller-Fabre, Virginie

    Published in PloS one (30-10-2012)
    “…Phthalates have been shown to have reprotoxic effects in rodents and human during fetal life. Previous studies indicate that some members of the nuclear…”
    Get full text
    Journal Article
  6. 6

    Nuclear receptors and endocrine disruptors in fetal and neonatal testes: a gapped landscape by Rouiller-Fabre, Virginie, Guerquin, Marie Justine, N'Tumba-Byn, Thierry, Muczynski, Vincent, Moison, Delphine, Tourpin, Sophie, Messiaen, Sébastien, Habert, René, Livera, Gabriel

    Published in Frontiers in endocrinology (Lausanne) (07-05-2015)
    “…During the last decades, many studies reported that male reproductive disorders are increasing among humans. It is currently acknowledged that these…”
    Get full text
    Journal Article
  7. 7

    In vitro effects of Uranium on human fetal germ cells by Angenard, Gaëlle, Muczynski, Vincent, Coffigny, Hervé, Duquenne, Clotilde, Frydman, René, Habert, René, Livera, Gabriel, Rouiller-Fabre, Virginie

    Published in Reproductive toxicology (Elmsford, N.Y.) (01-05-2011)
    “…Uranium (U) is found in the environment and its use in industrial or military activities has led to concerns about its potential toxicity. The reprotoxicity of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    AAV mediated gene therapy for haemophilia B: From the early attempts to modern trials by Muczynski, Vincent, Nathwani, Amit C.

    Published in Thrombosis research (01-04-2024)
    “…Early gene therapy clinical trials for the treatment of Haemophilia B have been instrumental to our global understanding of gene therapy and have significantly…”
    Get full text
    Journal Article
  10. 10

    AAV-Mediated Expression of a Single-Chain FVIII Mimetic Antibody Efficiently Corrects Bleeding in Haemophilia a Mice by Muczynski, Vincent, Bun, Eric, Tanner, Lewis, McIntosh, Jenny H., Christophe, Olivier D., Nathwani, Amit C.

    Published in Blood (02-11-2023)
    “…Background: The recent approval of gene therapy for haemophilia A (HA) using adeno-associated viruses (AAVs) marks an important and long-awaited landmark as it…”
    Get full text
    Journal Article
  11. 11

    A next generation inducible armored CAR to overcome the immunosuppressive tumor microenvironment and enhances cytotoxicity of CAR-T and TILs by Granger, David, Harrasser, Micaela, Evans, Rachel, Muczynski, Vincent, Chester, Kerry, Nathwani, Amit C.

    Published in Journal of clinical oncology (01-06-2022)
    “…e14517 Background: The full potential of CAR-T cells in clinic is limited by the immunosuppressive tumour microenvironment (TME), which induces expression of…”
    Get full text
    Journal Article
  12. 12

    NVG-222: A First-in-Class Autoregulating Half-Life Extended ROR1xCD3 T Cell Engager Heralding a New Class of Safer Drugs by Granger, David, Muczynski, Vincent, Henne, Patricia, Baccaro, Annalisa, Fernando, Dinusha, Shah, Mittal, Devlin, John, O'Donovan, Kieran, Nathwani, Amit C.

    Published in Blood (02-11-2023)
    “…Background T cell engagers (TCEs) are realizing their promise in both liquid and solid tumours, with several approvals in the last two years and many more in…”
    Get full text
    Journal Article
  13. 13

    A hemophilia A mouse model for the in vivo assessment of emicizumab function by Ferrière, Stephen, Peyron, Ivan, Christophe, Olivier D., Kawecki, Charlotte, Casari, Caterina, Muczynski, Vincent, Nathwani, Amit, Kauskot, Alexandre, Lenting, Peter J., Denis, Cécile V.

    Published in Blood (06-08-2020)
    “…The bispecific antibody emicizumab is increasingly used for hemophilia A treatment. However, its specificity for human factors IX and X (FIX and FX) has…”
    Get full text
    Journal Article
  14. 14

    Osteoprotegerin modulates platelet adhesion to von Willebrand factor during release from endothelial cells by Wohner, Nikolett, Sebastian, Silvie, Muczynski, Vincent, Huskens, Dana, de Laat, Bas, de Groot, Philip G, Lenting, Peter J

    Published in Journal of thrombosis and haemostasis (01-03-2022)
    “…Background Platelet‐binding Von Willebrand Factor (VWF) strings assemble upon stimulated secretion from endothelial cells. Objectives To investigate the…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    NVG-111, a novel ROR1xCD3 bispecific antibody for non-Hodgkin lymphoma by Granger, David, Gohil, Satyen, Barbarulo, Alessandro, Baccaro, Annalisa, Muczynski, Vincent, Chester, Kerry, Germaschewski, Fiona, Batten, Toby, Brown, Kathryn, Cook, Sarah, O'Donovan, Kieran, Jasani, Parag, Nathwani, Amit C., Phillips, Peter

    Published in Journal of clinical oncology (20-05-2021)
    “…Abstract only 7549 Background: Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) is a type I transmembrane protein is highly expressed on an array of…”
    Get full text
    Journal Article